U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Compositions and methods for stimulating bone growth

Patent 6022887 Issued on February 8, 2000. Estimated Expiration Date: Icon_subject December 12, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
Patent #: 5258376
Issued on: 11/02/1993
Inventor: Bernstein

Methods for reducing bone loss using centchroman derivatives
Patent #: 5280040
Issued on: 01/18/1994
Inventor: Labroo, et al.

Methods for inhibiting bone loss with bis-pyrone oxovanadium compounds
Patent #: 5545661
Issued on: 08/13/1996
Inventor: Cullinan

Lactone compound and process of production thereof Patent #: 5604257
Issued on: 02/18/1997
Inventor: Tabe, et al.

Inventors

Assignee

Application

No. 989862 filed on 12/12/1997

US Classes:

514/451, The hetero ring is six-membered514/460, Chalcogen bonded directly to ring carbon of the hetero ring549/273The lactone ring is six-membered

Examiners

Primary: Kunz, Gary L.
Assistant: Moran, Marjorie A.

Attorney, Agent or Firm

International Classes

A01N 043/16
C07D 309/00

Abstract

Compounds of the formula ##STR1## wherein X in each of formulas (1) and (2) represents a substituted or unsubstituted alkylene, alkenylene, or alkynylene linker of 2-6C;Y represents one or more carbocyclic or heterocyclic rings; when two or more rings are present in Y, they may optionally be fused; andR' represents a cation, H or a substituted or unsubstituted alkyl group of 1-6C; andthe dotted lines represent optional π-bonds,promote bone formation and are thus usefull in treating osteoporosis, bone fracture or deficiency, primary or secondary hyperparathyroidism, periodontal disease or defect, metastatic bone disease, osteolytic bone disease, post-plastic surgery, post-prosthetic joint surgery, and post-dental implantation.

Other References

  • Mundy, G.R., "Regulation of Bone Formation by Bone Morphogenetic Proteins and Other Growth Factors," Clinical Orthopaedics and Related Research 323:24-28 (Mar. 1996)
  • Mundy, G.R., "Cytokines and Growth Factors in the Regulation of Bone Remodeling," Journal of Bone and Mineral Research 8(S2):S505-S510 (Dec. 1993)
  • Wozney, J.M., et al., "Novel Regulators of Bone Formation: Molecular Clones and Activities," Science (Dec. 16, 1988) 242:1528-1534
  • Urist, M.R., "Bone: Formation by Autoinduction," Science (Nov. 12, 1965) 150:893-899
  • Wozney, J.M., "The Bone Morphogenetic Protein Family and Osteogenesis," Molecular Reproduction and Development 32:160-167 (Jun. 1992)
  • Harris, S.E., et al., "Effects of Transforming Growth Factor ଲon Bone Nodule Formation and Expression of Bone Morphogenetic Protein 2, Osteocalcin, Osteopontin, Alkaline Phosphatase, and Type I Collagen mRNA in Long-Term Cultures of Fetal Rat Calvarial Osteblasts," Journal of Bone Mineral Research 9(6):855-863 (Jun. 1994)
  • Stein, G.S., et al., "Bone cell differentiation: a functionally coupled relationship between expression of cell-growth-and tissue-specific genes," Current Opinion in Cell Biology 2:1018-1027 (Dec. 1990)
  • Wang, G-J., et al., "Lipid Clearing Agents in Steroid-induced Osteoporosis," J Formos Med Assoc 94(10):589-592 (Oct. 1995)
  • Cui, Q., et al., "Lovastatin Prevents Steroid-Induced Adipogenesis and Osteoporosis," Reports of the ASBMR 18th Annual Meeting (Sep. 1996) Journal of Bone and Mineral Research (Aug. 1996) 11 (Supplement 1):S510, p. S217
  • Bellows, C.G., et al., "Determination of the Capacity for Proliferation and Differentiation of Osteoprogenitor Cells in the Presence and Absence of Dexamethasone,"Developmental Biology 140:132-138 (Jul. 1990)
  • Rickard, D.J., et al., "Induction of Rapid Osteoblast Differentiation in Rat Bone Marrow Stromal Cell Cultures by Dexamethasone and BMP-2," Developmental Biology 161:218-228 (Jan. 1994)
  • Ducy, P., et al., "Increased bone formation in osteocalcin-deficient mice," Nature (Aug. 1, 1996) 382:448-45
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?